The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second ...

We recently published a list of 10 Best Dividend Kings Stocks to Invest in Now. In this article, we are going to take a look ...

BSNL, India’s leading telecom service provider has introduced a game-changing recharge plan which is gearing up the competition with private telecom giants like Jio, Airtel and Vodafone-Idea.

Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May ...

The recommended dose for Skyrizi is 150 mg – administered by two subcutaneous injections every 12 weeks following two initiation doses at week 0 and 4. It can be administered in-office or by ...

Sales of Skyrizi and Rinvoq grew by 50% and 45% ... According to some projections, the weight loss arena will be worth $150 billion by the early 2030s. Amgen's candidate seems to work, and ...

Sales of Skyrizi and Rinvoq grew by 50% and 45% ... According to some projections, the weight loss arena will be worth $150 ...

This week also saw a notable surge from pharmaceutical company AbbVie, with their drug Skyrizi, which leaped from 32nd to 4th place. PayPal, T-Mobile, and Vicks also made solid showings ...

The 2024 Ford F-150 Raptor remains one of the top factory off-road trucks you can buy today. You can even go extreme and get the Raptor R with its 5.2-liter supercharged V-8 chucking out 720 hp ...

The most important therapies in its lineup that are helping smooth out Humira-related losses are the immunology superstars Skyrizi and Rinvoq. In the third quarter, AbbVie's top line increased by ...

Nvidia (NASDAQ: NVDA) has dominated the 2024 stock market, driven by its artificial intelligence (AI) chips leadership, with investors eyeing the elusive $150 mark. At the close of the last trading ...